Scholar Rock Holding Corp (SRRK)
15.10
+0.14
(+0.97%)
USD |
NASDAQ |
May 02, 16:00
15.10
0.00 (0.00%)
After-Hours: 20:00
Scholar Rock Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2022 | 0.293 |
| December 31, 2021 | 0.2906 |
| September 30, 2021 | 0.1331 |
| June 30, 2021 | 0.1147 |
| March 31, 2021 | 0.1029 |
| December 31, 2020 | 0.0946 |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.0028 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.293
Maximum
Mar 2022
0.0857
Average
0.0473
Median
Debt to Equity Ratio Benchmarks
| Regeneron Pharmaceuticals Inc | 0.0763 |
| Ocular Therapeutix Inc | 0.8222 |
| Alpine Immune Sciences Inc | 0.00 |
| Keros Therapeutics Inc | 0.00 |
| X4 Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 311.04M |
| Total Liabilities (Quarterly) | 85.82M |
| Shareholders Equity (Quarterly) | 225.22M |